Nantahala Capital Management, LLC Chembio Diagnostics, Inc. Transaction History

Nantahala Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$3.28 - $5.93 $822,601 - $1.49 Million	-250,793 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$3.18 - $15.54 $3.76 Million - $18.4 Million	-1,181,239 Reduced 82.49%	250,793 $815,000
Q1 2020 May 14, 2020	BUY	$2.36 - $5.6 $453,235 - $1.08 Million	192,049 Added 15.49%	1,432,032 $7.33 Million
Q2 2019 Aug 14, 2019	BUY	$5.56 - $7.85 $500,305 - $706,366	89,983 Added 7.82%	1,239,983 $7.55 Million
Q1 2019 May 15, 2019	BUY	$5.32 - $7.18 $1.76 Million - $2.37 Million	330,000 Added 40.24%	1,150,000 $6.38 Million
Q4 2018 Feb 14, 2019	BUY	$4.95 - $10.5 $4.06 Million - $8.61 Million	820,000 New	820,000 $4.64 Million

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of Nantahala Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nantahala Capital Management, LLC with notifications on news.